Technical Analysis for NFX - Nuformix Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 7.03% | |
| New 52 Week Closing Low | Bearish | 7.03% | |
| Below Lower BB | Weakness | 7.03% | |
| Gapped Down | Weakness | 7.03% | |
| Lower Bollinger Band Touch | Weakness | 7.03% | |
| 20 DMA Support | Bullish | -3.41% | |
| Hammer Candlestick | Bullish | -3.41% | |
| Lizard Bullish | Bullish Day Trade Setup | -3.41% | |
| Doji - Bullish? | Reversal | -3.41% | |
| Lower Bollinger Band Touch | Weakness | -3.41% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | 38 minutes ago |
| 20 DMA Resistance | 38 minutes ago |
| 10 DMA Resistance | 38 minutes ago |
| Gap Up Closed | about 5 hours ago |
| Down 2% | about 6 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of multiple fibrotic diseases. NXP003 targets a mechanism understood to confer resistance to immuno-oncology, chemotherapy and radiotherapy cancer treatments.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharmaceutical Medicine Cancer Disease Pipe Clinic Drugs Diseases Radio Oncology Therapy Resistance Radiation Therapy Vr Fibrosis Chemotherapy Crystallography Cancer Treatments Radiotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharmaceutical Medicine Cancer Disease Pipe Clinic Drugs Diseases Radio Oncology Therapy Resistance Radiation Therapy Vr Fibrosis Chemotherapy Crystallography Cancer Treatments Radiotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.44 |
| 52 Week Low | 0.18 |
| Average Volume | 2,351,481 |
| 200-Day Moving Average | 0.28 |
| 50-Day Moving Average | 0.22 |
| 20-Day Moving Average | 0.20 |
| 10-Day Moving Average | 0.20 |
| Average True Range | 0.02 |
| RSI (14) | 36.71 |
| ADX | 31.34 |
| +DI | 17.55 |
| -DI | 7.81 |
| Chandelier Exit (Long, 3 ATRs) | 0.16 |
| Chandelier Exit (Short, 3 ATRs) | 0.25 |
| Upper Bollinger Bands | 0.21 |
| Lower Bollinger Band | 0.18 |
| Percent B (%b) | 0.0 |
| BandWidth | 14.73 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | 0.0015 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.21 | ||||
| Resistance 3 (R3) | 0.21 | 0.20 | 0.20 | ||
| Resistance 2 (R2) | 0.20 | 0.20 | 0.20 | 0.20 | |
| Resistance 1 (R1) | 0.19 | 0.19 | 0.19 | 0.19 | 0.20 |
| Pivot Point | 0.19 | 0.19 | 0.18 | 0.19 | 0.19 |
| Support 1 (S1) | 0.18 | 0.18 | 0.18 | 0.18 | 0.17 |
| Support 2 (S2) | 0.17 | 0.18 | 0.17 | 0.17 | |
| Support 3 (S3) | 0.16 | 0.17 | 0.17 | ||
| Support 4 (S4) | 0.16 |
